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ABSTRACT The assembly and composition of human ex-
cision nuclease were investigated by electrophoretic mobility
shift assay and DNase I footprinting. Individual repair factors or
any combination of up to four repair factors failed to form
DNA–protein complexes of high specificity and stability. A stable
complex of high specificity can be detected only when XPAyRPA,
transcription factor IIH, XPCzHHR23B, and XPG and ATP are
present in the reaction mixture. The XPFzERCC1 heterodimer
changes the electrophoretic mobility of the DNA–protein com-
plex formed with the other five repair factors, but it does not
confer additional specificity. By using proteins with peptide tags
or antibodies to the repair factors in electrophoretic mobility
shift assays, it was found that XPA, replication protein A,
transcription factor IIH, XPG, and XPFzexcision repair cross-
complementing 1 but not XPCzHHR23B were present in the
penultimate and ultimate dual incision complexes. Thus, it
appears that XPCzHHR23B is a molecular matchmaker that
participates in the assembly of the excision nuclease but is not
present in the ultimate dual incision complex. The excision
nuclease makes an assymmetric DNase I footprint of '30 bp
around the damage and increases the DNase I sensitivity of the
DNA on both sides of the footprint.
Human excision nuclease is the enzymatic activity resulting from
concerted action of 14–16 polypeptides in six repair factors (1);
it makes dual incisions bracketing the lesion in the damaged
strand and releases the damage in the form of 24–32 nt-long
oligomers (2). Recently, the enzyme system has been reconsti-
tuted from highly purified subunits consisting of XPA, replication
protein A (RPA), transcription factor IIH (TFIIH),
XPCzHHR23B, XPG, and XPFzERCC1 repair factors (3–5). By
using substrates with single lesions at predetermined sites and
either purified repair factors (6) or cell extracts from wild-type
and mutant cell lines (7), it was found that the dual incision event
is preceded by unwinding of DNA by 20–25 bp by the bidirec-
tional helicase activity of the TFIIH subunit. The study with
purified proteins identified three reaction intermediates, named
preincision complexes 1, 2, and 3 (PIC1, 2, and 3) on the pathway
to dual incisions (6). These studies have provided considerable
insight into the reaction mechanism of human excision nuclease.
However, two important issues regarding the mechanism have
remained unresolved: (i) Is there a damage recognition factor as
such, and, if there is, how does it recruit the other repair factors
to the site of damage? (ii) Do all of the repair factors assemble
together to form a complex capable of performing dual incisions
or do some of the factors function as molecular matchmakers (8),
that is, help in the assembly of the enzyme but are absent in the
ultimate dual incision complex?
By using randomly damaged DNA as substrate and a variety of
methods including filter binding and gel retardation assays for
detecting DNA–protein complexes, it has been shown that RPA
(9, 10), XPA (11, 12), the combination of XPA and RPA (13, 14),
and XPC (15) bind with moderately higher affinity to damaged
DNA compared with undamaged DNA. However, there are no
reports on the interactions of these proteins with DNA fragments
containing a single lesion. Hence, the designation of any of these
proteins or combinations thereof as ‘‘the damage recognition
factor’’ of human excinuclease must be considered provisional.
Similarly, although it has been shown conclusively that all six
factors are required for dual incisions (3, 4) and that five factors
but not XPCzHHR23B are required for excision of a lesion
adjacent to or within a mismatch ‘‘bubble’’ (6, 16), the compo-
sition of the reaction intermediate of the excision reaction has not
been determined.
In this study, we have identified the minimum set of repair
factors required for formation of a high affinity and specificity
DNA–protein complex and physically have separated this com-
plex from the free DNA and proteins in the reaction mixture by
electrophoresis on nondenaturing polyacrylamide gels. Physical
separation, in turn, has enabled us to probe the protein compo-
sition of the complex by ‘‘supershift’’ assays and the region of the
substrate in contact with the proteins by DNase I footprinting.
Our data show that XPA, RPA, TFIIH, XPCzHHR23B, and XPG
are required for high specificity DNA–protein complex formation
and that XPCzHHR23B is a molecular matchmaker that is not
present in the ultimate dual incision complex that covers an
'30-bp region of DNA around the lesion.
MATERIALS AND METHODS
Substrates. The substrate used in most of our binding exper-
iments was a 136-bp duplex containing a (6–4) photoproduct in
the center. The sequence and preparation of this substrate have
been described (17). The duplex contained 32P radiolabel either
at the 59 terminus of the damaged or complementary strand or
at the 4th phosphodiester bond 59 to the (6–4) photoproduct. The
substrate with a 10-nt ‘‘bubble’’ 59 to a cyclobutane thymine
dimer, which is referred to as T,.T (59-10), was prepared as
described elsewhere (6).
Repair Factors. Recombinant RPA (18), MBP-XPA (19),
(His)6–XPA (4), XPC and XPCzHHR23B (15), XPFzERCC1
(20), and XPG (21) were purified as described. The TFIIH was
purified from HeLa cells by the method of Mu et al. (4) and
contained eight subunits. In certain experiments, rat TFIIH of
high purity (22) was substituted for the human TFIIH.
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Antibodies. Antibodies against the p70 and p34 subunits of
RPA were obtained from Oncogene Science, and antibody
against the p62 subunit of TFIIH was purchased from Santa Cruz
Biotechnology. The polyclonal and monoclonal XPB antibodies
were as described (23, 24). mAb against XPC was provided by Eva
Lee (University of Texas, San Antonio, TX).
Electrophoretic Mobility Shift Assay. DNA (3 fmol) and
proteins at the indicated concentrations (XPA, 50 ng; RPA, 300
ng; TFIIH, 300 ng; XPCzHHR23B, 10 ng; XPG, 10 ng) were
incubated in 25 ml of excision buffer containing 30 mM
HepeszKOH (pH 7.9), 50 mM KCl, 4 mM MgCl2, 0.2 mM EDTA,
0.1 mM DTT, and 2 mM ATP. Incubation was at 30°C for 30 min.
Then, the sample was loaded directly onto a 0.25 3 20 3 40-cm
polyacrylamide gel (3.5% polyacrylamide) in 0.5 3 TBE (25 mM
Triszborate, pH 7.9y0.6 mM EDTA) containing 1 mM ATP and
10 mM MgCl2. Electrophoresis was carried out in 0.5 3 TBE
containing 1 mM ATP and 10 mM MgCl2 at 4°C and 150 V for
16–18 h. DNA–protein complexes were visualized by autoradiog-
raphy. In reactions containing the XPFzERCC1 complex, the
DNA was first incubated with the other repair factors at 30°C for
30 min; then, the mixture was put on ice, XPFzERCC1 was added
to the desired amount (20 ng) and, after 10 min of incu-
bation on ice, the sample was loaded onto the polyacrylamide gel.
DNase I Footprinting. DNA plus protein mixtures were pre-
pared as described above, and then CaCl2 was added to 4 mM
followed by 0.002 units of DNaseI from Life Technologies (Grand
Island, NY). The mixture was incubated at room temperature for
3 min and then loaded onto a 3.5% nondenaturing polyacryl-
amide gel to separate free DNA from DNA–protein complexes.
The free and protein-bound DNA were located by autoradiog-
raphy, the bands were excised, the DNAs were eluted from
polyacrylamide matrix, and then the DNAs with equal amount of
radioactivities were analyzed on 6% denaturing polyacrylamide
gels along with Maxam-Gilbert G1A chemical sequence ladder.
RESULTS
Lack of High Specificity Damage Recognition by Individual
Repair Factors. Damage-specific binding has been reported for
RPA (9, 10), XPA (11), and XPCzHHR23B (15). However, the
discrimination between damaged and undamaged DNA reported
in these studies was modest. Furthermore, these studies were
conducted with randomly damaged DNAs and as a consequence
had additional limitations vis-a-vis the affinity of a given protein
for a given type of lesion and the ability of the repair protein to
discriminate between damaged and undamaged DNA. Such data
can be obtained most unambiguously by investigating the inter-
action of purified proteins with a pure substrate, that is, a
substrate that contains a known lesion at a known site (25). The
DNA–protein complexes that form under these conditions can be
characterized qualitatively by DNase I footprinting and quanti-
tatively by electrophoretic mobility shift assay (gel retardation).
Repeated attempts to obtain conventional DNase I footprints of
XPA, RPA, TFIIH, XPCzHHR23B, XPG, and XPFzERCC1 or
various pairwise combinations of these repair factors with various
substrates failed to elicit specific DNA–protein complexes.
Hence, we decided to search for specific DNA–protein complexes
by the gel retardation assay.
Fig. 1A shows the results of a gel retardation assay performed
with five excision repair factors individually and with the XPA 1
RPA combination that has been reported to confer higher
specificity than either factor alone (13, 14). The concentrations of
the factors were chosen such that the combination of all six repair
factors yielded high efficiency of excision (Fig. 1B). With a
136-mer containing a centrally located (6–4) photoproduct as a
probe, XPA has a modestly higher (1.9-fold) affinity to damaged
DNA than to undamaged DNA (Fig. 1, lanes 3 and 4); RPA does
not have measurable affinity to either probe under our assay
conditions (Fig. 1, lanes 5 and 6), but the presence of RPA in the
XPA 1 DNA mixture increases the fraction of both nonspecific
(Fig. 1, lane 7) and specific (Fig. 1, lane 8) DNA–protein
complexes without affecting specificity. Of interest, the DNA–
protein complexes that form with XPA 1 RPA have the same
mobility as the complex formed with XPA alone (compare Fig.
1 lanes 3 and 4 with 7 and 8). However, because the XPA 1 RPA
combination did not increase the specificity, the composition of
the complex that forms with these two factors was not investigated
any further. In agreement with a previous report (15),
XPCzHHR23B also bound (6–4) photoproduct-containing DNA
with a slightly higher affinity than undamaged DNA (Fig. 1, lanes
9 and 10). However, again, the discrimination between undam-
aged and damaged DNA was not sufficiently high to qualify the
XPCzHHR23B protein as ‘‘the damage recognition subunit’’ of
human excinuclease. Finally, neither TFIIH nor XPG bound to
DNA under the conditions used in our experiment (lanes 11–14).
Formation of a High Specificity DNA–Protein Complex with
Human Excinuclease. Experiments with all combinations of two
and three repair factors failed to improve the specificity of binding
in the gel retardation assay. In contrast, the four repair factors
XPA, RPA, TFIIH, and XPCzHHR23B, known from perman-
ganate footprinting experiments to unwind DNA around the
lesion and hence to make a specific complex called PIC1 (6), did
indeed form a slow-migrating DNA–protein band with the (6–4)
photoproduct substrate (Fig. 2A, lane 2). However, the DNA
within this complex was a minor fraction of input DNA indicating
that the complex was rather unstable. Addition of XPG to the
reaction mixture greatly increased the fraction of the DNA in the
complex (Fig. 2, lane 3), again in agreement with the results of
permanganate footprinting, which suggested that XPG greatly
stabilizes the DNA–protein complex formed at the lesion site by
XPA, RPA, TFIIH, and XPCzHHR23B proteins converting it to
PIC2 (6). Important to note, no detectable complex is formed
when unmodified DNA is used in gel retardation experiments
(Fig. 2, lane 5) even in the presence of XPG. Thus, the damage
specific complex we have identified with human excision nuclease
(Fig. 2, lane 3) differs from all previously reported excision repair
factor protein–DNA complexes in degree of its selectivity be-
cause the ratio of damage-specific to nonspecific binding with five
repair factors is '50 (Fig. 2, lanes 3 and 5). Furthermore, the
formation of this high specificity complex depends on all five
repair factors; as can be seen from Fig. 2B, omission of any of the
four factors, XPA, RPA, TFIIH, or XPCzHHR23B, completely
abolishes specific complex formation. In comparison, XPG omis-
FIG. 1. Damage-specific binding and excision. (A) Binding of
human excision repair factors to damaged DNA. Repair factors were
incubated for 30 min with either a 136-bp control DNA or a duplex
containing (6–4) photoproduct and were analyzed on a nondenaturing
gel (lanes 1–14). (B) Excision reaction by repair factors used in binding
assay. The (6–4) substrate was incubated for 2 h with the five repair
factors (RFI–V: XPA, RPA, TFIIH, XPC, XPG) at the concentration
used in binding experiment and XPFzERCC1 (RFVI). Excision prod-
ucts were analyzed on 8% denaturing polyacrylamide gel. Quantitative
analysis shows that 93% of the damage was excised.
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sion greatly destabilizes the complex without totally eliminating
binding (compare Fig. 2A, lanes 2 and 3, with Fig. 2B, lanes 2–6).
Finally, as expected, the formation of the damaged DNA–human
excision nuclease complex has an absolute requirement for ATP
(Fig. 2C, lanes 2 and 4), in agreement with the permanganate
probing experiments that revealed specific unwinding of dam-
aged DNA only in the presence of ATP (6).
Binding of XPFzERCC1 to the Specific DNA–Protein Complex.
The data presented so far are consistent with the formation of a
specific excision nuclease complex with five of the six repair
factors that constitute the human excinuclease. If the damaged
DNA–protein complex we detect is an intermediate on the
pathway for dual incisions then it is expected to bind to the sixth
repair factor, the XPFzERCC1 heterodimer. This factor is the
nuclease that makes the 59 incision (21, 26), and kinetic experi-
ments indicate that it enters the excinuclease complex last (4, 6).
Hence, we decided to investigate the effect of XPFzERCC1 on the
electrophoretic mobility of the complex that forms with XPA,
RPA, TFIIH, XPCzHHR23B, and XPG and that we refer to as
PIC2.
Because incubation of substrate with the six repair factors leads
to dual incisions and disassembly of the enzyme (4), we conducted
these experiments under conditions not conducive to dual inci-
sions. We used two experimental approaches for this purpose. In
one, PIC2 was assembled at 30°C then put on ice, XPFzERCC1
was added to the mixture, and after another 10-min incubation at
this temperature the sample was loaded onto a gel. Fig. 3 (lanes
2 and 3) shows that XPFzERCC1 does associate with PIC2 and
causes further retardation (‘‘supershift’’) of the complex. In
accordance with the nomenclature used previously (6), we refer
to the complex that forms with all six repair factors PIC3. In the
second experimental approach, we used an active site XPG
mutant in the initial assembly reaction. Previously, we showed
that association of XPFzERCC1 with PIC2 was independent of
the 39 nuclease activity of XPG (6, 27). Indeed, as probed by
electrophoretic mobility shift assay, the XPG active site mutant
XPG-D812A forms PIC2 with the same efficiency as the wild-
type XPG. Similarly, the PIC2 with the mutant XPG protein is
supershifted by XPFzERCC1 complex (Fig. 3, lanes 4 and 5).
These data taken together with previous studies on the role of
XPG in assembly (6, 27) are consistent with the notion that the
damage-specific complex formed by the five repair factors (PIC2)
is on the pathway to dual incision as is the complex (PIC3) that
forms upon addition of the sixth repair factor, the XPFzERCC1
heterodimer.
Subunit Composition of Human Excinuclease. Previous stud-
ies on assembly of human excinuclease did not address the
question of protein composition of preincision complexes. There
are two possible scenarios. In one model, one or more of the
repair factors act as molecular matchmakers, which in an ATP-
dependent manner promote the formation of the dual incision
complex but are not part of this complex (8). In the second
scenario, the repair factors assemble in a preordained sequence
and all are present in the ultimate, dual incision complex.
To differentiate between these two models, we probed the
composition of PIC3 by using protein tags and antibodies to the
FIG. 2. Detection of preincision complexes 1 and 2 by electro-
phoretic mobility shift assay. (A) Weak PIC1 forms with RFI-IV
(XPA, RPA, TFIIH, and XPC) (lane 2), which is stabilized by XPG to
form PIC2 (lane 3). No PIC2 can be detected with unmodified DNA
(lane 5). (B) Formation of PIC2 requires all five repair factors. (C)
PIC2 formation is ATP-dependent. Reaction mixtures were incubated
in the presence or absence of ATP and separated on a 3.5% nonde-
naturing polyacrylamide gel as indicated. Open arrow shows the
binding by a minor contaminant in the TFIIH factor.
FIG. 3. Detection of preincision complex 3 by electrophoretic
mobility shift assay. The substrate was incubated with RFI-IV (XPA,
RPA, TFIIH, XPC) and either wild-type or mutant XPG at 30°C to
form PIC2 (1st incubation), then XPFzERCC1 was added on ice as
indicated (second incubation), and the DNA–protein complexes were
analyzed by electrophoretic mobility shift assay.
FIG. 4. Detection of repair factors in PIC3. (A) The PIC3 formed
with MBP-XPA migrates slower than the complex formed with smaller
(His)6–XPA. (B) Antibodies to p70 and p34 subunits of RPA super-
shift PIC3. (C) Polyclonal antibodies to the XPB subunit of TFIIH
supershift (lane 4); monoclonal XPB and polyclonal p62 antibodies
disrupt PIC3 (lanes 3 and 5). PIC3* indicates supershifted PIC3.
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repair factors in electrophoretic mobility supershift experiments.
(i) We tested for the presence of XPA by comparing the migration
of PIC3s formed with (His)6–XPA and MBP-XPA. Fig. 4A shows
that PIC3 formed with the two forms of XPA have different
mobilities, which proves that XPA is in the ultimate incision
complex. (ii) Similarly, Fig. 4B shows that PIC3 is supershifted by
antibodies against the p70 and p34 subunits of RPA, thus
revealing that RPA also is in the incision complex. (iii) TFIIH also
is in the complex because polyclonal antibodies against the XPB
subunits supershift PIC3, and monoclonal and polyclonal anti-
bodies against the XPB and p62 subunits disrupt PIC3 (Fig. 4B).
(iv--v) Physical presence of XPG and XPFzERCC1 is evident
from the fact that incubating the complex at 30°C leads to dual
incisions.
XPC as a Molecular Matchmaker. Preliminary experiments
suggested that XPCzHHR23B may not be present in PIC2 and
PIC3. Because this was a rather unexpected result, we probed for
XPC in these complexes by three different methods. First, we
compared the electrophoretic mobilities of PIC3 with two forms
of XPC. Under physiological conditions, nearly all of XPC is in
a complex with HHR23B in the form of XPCzHHR23B het-
erodimer (28). However, it was found that XPC alone was as
active as (15) or slightly less active (29) than the heterodimer in
reconstituting human excinuclease. Thus, to find out whether
XPC is present in PIC3, we used either the heterodimer or the
XPC monomer in the reaction and compared the mobility of the
two complexes. Fig. 5A shows that the PIC3s formed in the
presence of these two forms of the XPC factor have the same
mobility. However, the molecular mass of HHR23B is only 58
kDa (28), and hence it is conceivable that, even if XPC were part
of PIC3, the effect of HHR23B on migration of a complex of
'800–900 kDa would not be as pronounced as it is on the
XPCzDNA complex alone (15) in our system, even though the
effect of MBP ('40 kDa) could be detected as shown in Fig. 4A.
Hence, we tested for the presence of XPC in PIC3 by using
anti-XPC antibodies in a supershift experiment. Fig. 5B shows
that XPC antibodies do not alter the electrophoretic migration of
PIC3 suggesting that XPC is absent from PIC3. This provisional
conclusion was supported by experiments performed with T,.T
(59-10) substrate, which contains a 10-nt mismatch (‘‘bubble’’) 59
to a cyclobutane thymine dimer. Previous work has shown that
the T,.T can be excised from this substrate by human exc-
inuclease reconstituted in the presence or absence of
XPCzHHR23B (6). Hence, this substrate was used in electro-
phoretic mobility shift assay with excinuclease reconstituted with
or without XPCzHHR23B. Fig. 5C shows that, although there is
some quantitative difference in the level of PIC3 formed, the
complexes formed under the two conditions co-migrate, again
consistent with the notion that XPC is absent from PIC3.
However, we were still concerned about whether the mass of
XPCzHHR23B was of sufficient magnitude to change the mo-
bility of PIC3 in our system. To address this point, we tested the
effect of XPCzHHR23B and XPG (which is comparable in mass
to XPCzHHR23B) on mobility of PIC1, which was formed
without XPC. The result is shown in Fig. 5D; XPCzHHR23B (lane
3) and XPG (lane 4) supershift PIC1 formed without
XPCzHHR23B (lane 2); however, the combination of the two
does not cause further retardation (lane 5). This result is consis-
tent with the notion that the entry of XPG to the preincision
complex is coincident with departure of XPCzHHR23B from the
complex. Thus, all of the data presented in Fig. 5 constitute strong
evidence that XPCzHHR23B is a molecular matchmaker that
does not participate in the dual incision step of excinuclease.
FIG. 5. Evidence for lack of XPC in PIC3. (A) PIC3s formed with either XPCzHHR23B or XPC have the same electrophoretic mobility. (B)
Anti-XPC antibodies do not supershift PIC3. (C and D) Band mobility shift assays with T,.T(59-10) ‘‘bubble’’ substrate. (C) PIC3s formed with
(lane 2) and without (lane 3) XPCzHHR23B have the same electrophoretic mobility. (D) XPCzHHR23B (lane 3) and XPG (lane 4) cause supershift
in PIC1 formed without XPCzHHR23B, but the combination of the two does not cause further retardation (lane 5).
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Footprint of Human Excinuclease. Previous work has shown
that '50 bp on the 59 side and 30 bp on the 39 side of damage are
required for optimal functioning of human excinuclease (30) and
provides an insight into the approximate extent of DNA–protein
interactions that would be expected in excinuclease–substrate
complex. To better define the DNA–protein interactions, we
performed DNase I footprinting experiments on PIC2, which is
the first high specificity and high stability complex detectable with
the human excinuclease. Even under optimum conditions for
excision most of the DNA is unbound (see Figs. 1 and 2), so it is
impossible to obtain footprint with the conventional DNase I
footprinting method. Similarly, our repeated attempts to perform
in situ footprinting on the retarded band in gel were unsuccessful
presumably because during the manipulations necessary for this
method PIC2 disassembles. Hence, we conducted footprinting
subjecting the complex to DNase I before gel electrophoresis. The
DNase I-treated reaction mixtures containing PIC2 were sepa-
rated on nondenaturing polyacrylamide gels, and DNAs in free
and bound fractions were eluted and analyzed on sequencing gels.
Fig. 6 shows that the DNase I-protected region does not extend
beyond 20 nt 59 and 15 nt 39 to the damage. Furthermore, it
appears that the DNA outside of the protected region is largely
hypersensitive to DNase I. It is possible that this hypersensitivity
is caused by wrapping of DNA around the proteins in the PIC2
complex. Significantly, the DNA near the 59 incision site is
hypersensitive to DNase I, consistent with minor groove widening
caused by kinking of DNA in this region.
DISCUSSION
Excision repair in eukaryotes in general and in humans in
particular has been investigated in considerable detail in recent
years (1, 31, 32). These studies have led to reasonably detailed
models for excision repair. However, two aspects of nucleotide
excision repair in humans have remained ill-defined: damage
recognition and the role of XPCzHHR23B.
Damage Recognition. Substrates for human excinuclease cover
the entire spectrum of damaged bases (2). Hence, specific chem-
ical groups on DNA cannot be determinants for recognition. It
appears that any abnormal DNA structure, but in particular
adducts that destabilize the helix, is recognized by the enzyme
system (17, 33, 34). Attempts to assign the damage recognition
function to specific repair factors have had limited success, which
is in part due to the fact that all six repair factors have affinity for
DNA and in part due to the finding that those that have been
reported to discriminate between damaged and undamaged
DNA, XPA (11, 12), RPA (9, 10), and XPCzHHR23B (15) do not
exhibit high enough specificity to account for the capacity of the
human excinuclease system to find the rare lesions within '1010
FIG. 6. DNase I footprint of PIC2. The 136-bp substrate with 59
label either in the strand containing the (6–4) photoproduct (top
strand) or in the complementary strand (bottom strand) was incubated
with the five repair factors (no XPFzERCC1) and digested with DNase
I, and then bound and unbound fractions were separated on nonde-
naturing polyacrylamide gels; DNA was eluted from the free and
bound fractions and analyzed on 6% denaturing polyacrylamide gels.
(A) Footprinting gels along with G1A sequence ladder. Solid and
open arrows show the site of (6–4) photoproduct. Brackets and arrow
indicate protected region and prominent hypersensitive sites. (B)
Schematic illustration of footprint of human excinuclease indicating
incision sites and protected region.
FIG. 7. Model for reaction mechanism of human excinuclease.
XPCzHHR23B is a molecular matchmaker that is not present in either
the penultmate or the ultimate dual incision complex. A, B, and D,
XPA, XPB, and XPD, respectively; Cy23B, XPCzHHR23B, G, XPG;
and FyE1, XPFzERCC1 complex.
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bp of human diploid DNA. It has been reported that the
combination of XPA and RPA improves specificity (13, 14).
However, as can be seen in Fig. 1, the improvement in selectivity
is modest and cannot account for the specificity of excision
nuclease. Similarly, it has been reported that XPA helps recruit
TFIIH to the damage site and thus promote a more stable
complex (35, 36). However, permanganate footprinting has
shown that the XPA 1 TFIIH combination alone does not lead
to unwinding around the damage (6), and with the defined
substrates used in this study, we failed to detect specific
XPAzTFIIHzDNA complexes. Instead, the first high specificity
complex we can detect with either the permanganate footprinting
or gel retardation assay requires the XPA1RPA1
XPCzHHR23B1TFIIH combination, and the specificity and
stability of the complex are further increased by XPG. Hence,
until the development of higher resolution data capable of
showing whether these four to five factors arrive at the damage
site sequentially or simultaneously, it might be prudent to refrain
from referring to any of these factors as the damage recognition
subunit. Clearly, XPA and RPA contribute by their affinities to
DNA, TFIIH by unwinding DNA around the lesion and facili-
tating the entry of XPCzHHR23B into the complex, and
XPCzHHR23B and XPG contribute to specificity by binding to
TFIIH and the ‘‘bubble’’ structure created by TFIIH and to RPA
(21) within the complex.
XPC as a Molecular Matchmaker. XP-C mutant cells and XPC
protein exhibit some unique features. First, XP-C cells have
'20% residual repair activity, all of which appears to be due to
normal level of repair of the template strand of transcribed genes
(37, 38). Second, in in vitro reconstitution experiments, it was
found that XPC is not required for excision of an artificial lesion
(cholesterol moiety substituted for a base) expected to cause
substantial unwinding (4). Finally, when a T,.T is adjacent to
a 10-nt bubble or within, a 20-nt bubble excision occurs indepen-
dent of XPCzHHR23B (6, 16). Of all basal factors for excision
repair, it thus appears that XPCzHHR23B is the only factor that
is dispensable under certain circumstances, in particular, under
conditions that favor DNA unwinding. It is possible that
XPCzHHR23B helps to position correctly the repair factors
within and around unwound DNA and in the process of doing so
must dissociate from the substrate for formation of a productive
preincision complex. Significantly, it appears that, during assem-
bly, XPCzHHR23B and XPG cannot exist in the complex simul-
taneously and that the entry of XPG into the complex coincides
with XPCzHHR23B leaving the complex. Whether
XPCzHHR23B plays a direct role in recruiting XPG cannot be
ascertained from our data. It is interesting that, depending on the
purification procedure used, either XPCzHHR23B (23) or XPG
(3), but not both, co-purify with TFIIH through several chro-
matographic steps. In addition, our data in conjunction with a
previous report (6) [that showed that unwinding of DNA around
the lesion to form PIC2 required TFIIH and XPC and could be
inhibited by the nonhydrolyzable ATP analog ATPgS (6)] show
that the formation of PIC2 and PIC3 promoted by XPCzHHR23B
depends on the ATPase function of TFIIH (22).
A molecular matchmaker is described as a protein that, in an
ATP-dependent reaction, brings target DNA and an effector
protein together, promotes a stable complex formation, and then
dissociates from the complex to enable the effector molecule to
engage in further protein–protein interactions or perform its
catalytic function on target DNA (8). Thus, by all of these criteria,
which originally were applied to the UvrA protein of Escherichia
coli excinuclease (8, 39), XPCzHHR23B is a molecular match-
maker. Taking the molecular matchmaker function of
XPCzHHR23B into account, we present the model shown in Fig.
7 as the current refinement of our understanding of the action
mechanism of human excinuclease. This model differs from other
models in two significant aspects. First, there is no ‘‘damage
recognition’’ subunit as such. Several proteins acting together find
the damage. Second, the entry of XPG into the complex coincides
with the exit of XPCzHHR23B from the complex and hence
XPCzHHR23B is absent from the dual incision complex.
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